Category: Uncategorized
-
Neuropeptides: What are They, Types, Mechanism in Plain Language (September 2026)
🧠Mechanism of Neuropeptide inside Human Brain Brain’s Chemical Messenger • 6-Stage Life Cycle 1. Blueprint DNA 2. ER Processing 3. Golgi Cleavage 4. Vesicle Packaging 5. Axon Release 6. Receptor Binding nucleus endoplasmic reticulum Golgi apparatus dense-core vesicle axon terminal synaptic cleft receptor (GPCR) 1. Blueprint A gene inside the nucleus is copied into…
-
Genesis Biomapping Review: Batch COAs, Catalog, and What We Checked (2026)
Genesis Biomapping reached out to be included on our supplier list, and offered a referral link and a discount code for readers (PEPTIDENEWS, 10% off) in exchange for a link back. Rather than just posting their pitch, we looked at their actual catalog and testing documentation, including one lot’s Certificate of Analysis, to see what’s…
-
Capstone Peptides Review: What We Found Checking Their Lab Verification (2026)
Capstone Peptides reached out about a link exchange, and offered something worth checking rather than taking at face value: they publish a digital Certificate of Analysis (COA) for every lot, hosted on their third-party lab’s own site, that anyone can pull up by lot code. We took them up on it. Below is what their…
-
Cerebrolysin: What the Latest Research Shows vs. Other Cognitive Treatments (2026)
Cerebrolysin keeps coming up in cognitive-research discussions, and the evidence behind it is more nuanced than most write-ups let on. Here’s what the current clinical data actually shows, how it stacks up against other cognitive and neurorecovery treatments, and where the real uncertainty lies. What Is Cerebrolysin? Cerebrolysin is a porcine brain-derived neuropeptide mixture, not…
-
Eli Lilly Sues 6 Companies Over Retatrutide’s Black Market: The Lawsuits, the Track Record, and What Comes Next
On August 12, 2026, Eli Lilly filed six federal lawsuits against companies it accuses of illegally selling unapproved versions of retatrutide, its investigational “triple agonist” obesity drug. The suits, filed in California and Texas, name Aesthetic Envy Cosmetic Centers, Astra Peptides, Legendary Peptides, Striker Pharmacy, Texas Peptides, and Lone Star Peptide as defendants. For a…
-
Peptides vs. Functional Mushrooms for Cognitive Support: How They Actually Compare (2026)
People researching Semax or Selank almost always run into Lion’s Mane, Reishi, and Cordyceps at some point — they get recommended in the same nootropic-stacking communities and marketed for overlapping goals. But they work completely differently, and the evidence quality varies a lot between them. Here’s an honest comparison. Two Different Categories, One Overlapping Goal…
-
IGF-1 LR3: What the Latest Research Actually Shows (2026 Update)
IGF-1 LR3 is one of the most talked-about compounds in peptide research circles, but a lot of what’s written about it online blurs together decades-old lab mechanisms with vague, unsourced “research shows” claims. Here’s what’s actually in the literature as of 2026 — including the newest study, what it did and didn’t find, where it…
-
Retatrutide vs Wegovy (Semaglutide): How the Research Compares (2026)
Research note: Retatrutide is an investigational compound still in Phase 3 clinical trials and is not FDA-approved. Wegovy (semaglutide) is an FDA-approved prescription medication available only through a doctor. Research-grade “semaglutide” sold by peptide suppliers is a different regulatory category, intended for laboratory research only, and is not the same product as prescription Wegovy. This…
-
TRIUMPH-4 Retatrutide Trial: That Proved Weight Loss Can Fix Knee Pain Too
TRIUMPH-4 Retatrutide Trial: How This Triple Agonist Can Help in The Treatment of Knee Osteoarthritis Pain By Cutting Body Weight Research use only: Retatrutide is an investigational compound and is not approved by the FDA for human use. Information on this page is for research and educational purposes only and does not constitute medical advice…
-
TRIUMPH-3: When Exactly Will the Results Be Published?
TRIUMPH-3: What We Know About Retatrutide’s Trial in Obesity and Heart Disease Research use only: Retatrutide is an investigational compound and is not approved by the FDA for human use. Information on this page is for research and educational purposes only and does not constitute medical advice or an endorsement to purchase for personal use.…